Christopher Raymond's Stock Ratings

Piper Sandler Analyst

Christopher Raymond is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024

Overall Average Return

14.4%

Smart Score

73.5%

Overall Average Return Percentile

70th

Number of Ratings

71
Buy NowGet Alert
05/07/2024VRTXBuy Now
Vertex Pharmaceuticals
$440.643.49%$450 → $456MaintainsOverweightGet Alert
05/03/2024BPMCBuy Now
Blueprint Medicines
$106.64-2.48%$78 → $104MaintainsNeutralGet Alert
04/29/2024ABVXBuy Now
Abivax
$13.80204.35% → $42Initiates → OverweightGet Alert
04/09/2024TSHABuy Now
Taysha Gene Therapies
$3.14186.62% → $9Initiates → OverweightGet Alert
04/02/2024QTTBBuy Now
Q32 Bio
$31.0045.16% → $45Initiates → OverweightGet Alert
03/08/2024ALXOBuy Now
ALX Oncology Holdings
$14.6643.25%$11 → $21MaintainsOverweightGet Alert
02/23/2024BMRNBuy Now
Biomarin Pharmaceutical
$76.9739.02%$115 → $107MaintainsOverweightGet Alert
02/23/2024ARDXBuy Now
Ardelyx
$7.8092.31%$12 → $15MaintainsOverweightGet Alert
02/14/2024BIIBBuy Now
Biogen
$230.0441.28%$350 → $325MaintainsOverweightGet Alert
12/22/2023ALVRBuy Now
AlloVir
$0.7599.63%$27 → $1.5DowngradeOverweight → NeutralGet Alert
11/15/2023BHVNBuy Now
Biohaven
$38.45-6.37%$29 → $36MaintainsOverweightGet Alert
11/03/2023KPTIBuy Now
Karyopharm Therapeutics
$1.13342.16%$7 → $5MaintainsOverweightGet Alert
11/03/2023REGNBuy Now
Regeneron Pharmaceuticals
$967.98-7.54%$885 → $895MaintainsOverweightGet Alert
11/02/2023BMRNBuy Now
Biomarin Pharmaceutical
$76.9749.41%$125 → $115MaintainsOverweightGet Alert
10/30/2023DCPHBuy Now
Deciphera Pharmaceuticals
$25.45-9.63%$18 → $23UpgradeNeutral → OverweightGet Alert
10/25/2023RAREBuy Now
Ultragenyx Pharmaceutical
$42.61205.09%$135 → $130MaintainsOverweightGet Alert
10/11/2023ALXOBuy Now
ALX Oncology Holdings
$14.66-24.97%$8 → $11MaintainsOverweightGet Alert
09/28/2023IOBTBuy Now
IO Biotech
$1.36635.29% → $10Initiates → OverweightGet Alert
09/19/2023KNTEBuy Now
Kinnate Biopharma
——$20 → $4DowngradeOverweight → NeutralGet Alert
08/11/2023ALXOBuy Now
ALX Oncology Holdings
$14.66-45.43%$48 → $8MaintainsOverweightGet Alert
08/03/2023KPTIBuy Now
Karyopharm Therapeutics
$1.13519.03%$8 → $7MaintainsOverweightGet Alert
07/28/2023ABBVBuy Now
AbbVie
$164.353.44%$163 → $170MaintainsOverweightGet Alert
06/12/2023COGTBuy Now
Cogent Biosciences
$7.47194.51% → $22MaintainsOverweightGet Alert
06/01/2023BIIBBuy Now
Biogen
$230.0456.49%$346 → $360MaintainsOverweightGet Alert
05/31/2023AKBABuy Now
Akebia Therapeutics
$1.13254.01%$2 → $4UpgradeNeutral → OverweightGet Alert
05/23/2023VECTBuy Now
VectivBio Holding
——$25 → $17DowngradeOverweight → NeutralGet Alert
05/12/2023MGTXBuy Now
MeiraGTx Hldgs
$5.68340.14%$26 → $25MaintainsOverweightGet Alert
05/04/2023VRTXBuy Now
Vertex Pharmaceuticals
$440.64-12.63% → $385Assumes → OverweightGet Alert
04/28/2023AMGNBuy Now
Amgen
$314.72-8.49%$293 → $288MaintainsOverweightGet Alert
04/27/2023BMRNBuy Now
Biomarin Pharmaceutical
$76.9762.4%$128 → $125MaintainsOverweightGet Alert